Michael F. Schaff co-leads the Corporate and Health Law groups at Wilentz, Goldman & Spitzer, P.A. Mr. Schaff counsels clients on the legal and business ramifications of any transaction, contract, agreement or negotiation by leveraging a diverse educational and professional background rooted in healthcare regulatory, business, finance and taxation. He represents start-ups and established businesses of all sizes as well as physician practices, private equity companies, hospitals, ambulatory surgical centers, clinically integrated networks, managed care organizations, physicians and other healthcare providers in strategic transactions with respect to entity formation, joint ventures, stock and asset acquisitions and sales, regulatory compliance, as well as simple to complex commercial agreements and contracts. He also advises clients in private equity investments in healthcare and telehealth.
Mr. Schaff earned his LL.M. degree at Boston University School of Law in Taxation in 1983 and his J.D. degree at New York Law School in 1982. He earned his MBA degree at City University of New York: Baruch College in 1982. He graduated from Rutgers University in 1979.
Full bio: https://www.wilentz.com/attorneys/michael-f-schaff.
American Heath Law Association Fellow; New Jersey State Bar Association Trustee and Executive Committee of General Counsel Co-Chair; NJSBA Health Law Section, Emeritus Director; NJSBA Cannabis Law Committee, Co-Chair; Seton Hall Law School’s Center for Health & Pharmaceutical Law & Policy, Advisory Board
For a complete list of Mr. Schaff’s publications, please visit his bio: https://www.wilentz.com/attorneys/michael-f-schaff.
Co-Author, “Health Care Transactions Manual: Understanding the Consequences of the Health Care Deal - Organizing the Health Care Transaction,” American Health Lawyers Association (2020)
Co-Author, “Opioid Prescribing: An AHLA 50 State Survey,” American Health Lawyers Association (2020)
Co-Author, “Expungement Reform Law Brings Sweeping Changes to Marijuana Convictions in NJ,” New Jersey Law Journal Cannabis Column (1/21/2020)
Co-Author, “Proliferation of Private Equity Investment in ASCs,” ASC Focus (1/1/2020)
Co-Author, “The Hemp Farming Act: One Step Forward in NJ,” New Jersey Law Journal Cannabis Column (12/12/2019)
Author, “Five Tips to Reduce Office Expenses,” New Jersey Lawyer (December 2019 edition)
Co-Author, “NJ’s Amended Medical Marijuana Law: Permits Needed for Alternative Treatment Center,” New Jersey Law Journal Cannabis Column (9/30/2019)
Co-Author, “Expansion of Medicinal Marijuana Is in NJ’s Future, but Adult Use May Not Be,” New Jersey Law Journal (6/19/2019)
Co-Author, “Private Equity Investment in Health Care,” American Health Lawyers Association Health Law Watch (2019)
Co-Author, “Dental Service Organizations Beware of New Jersey's Enhanced Restrictions,” Dorfman Mizrach & Thaler, LLP, Certified Public Accountants and Advisors (5/5/2019)
Co-Author, “INSIGHT: Physicians Can De-Stress Over Unwinding Hospital-Affiliated Medical Practices,” Bloomberg Law (10/22/2018)
Co-Author, “The Big Production About ASC Nonproduction,” ASC Physician Focus (7/30/2017)
Co-Author, “Representing Hospitals and Health Systems Handbook,” American Health Lawyers Association (2016)
Co-Author, “Clinically Integrated Networks: The New Way for Healthcare Providers to Play Together in the Sandbox,” New Jersey Lawyer (7/5/2016)
Co-Author, “Law Firm Breakup: What You Need to Know When Dissolving the Entity,” New Jersey Lawyer (3/9/2015)
Co-Author, “Hiring a New Doctor? Key Provisions For a Medical Practice to Include in Their Employment Agreements,” New Jersey Medical Group Management Association (Spring 2015 Newsletter)
Author, “Telemedicine and the Impediments Facing Effective Implementation,” American Health Lawyers Association (1/15/2015)
David J. Greenburg Service Award
American Health Lawyers Association
Distinguished Service Award
New Jersey Institute for Continuing Legal Education
Leading Healthcare Transactional Lawyer Award
Ambulatory M&A Advisor